The UK Consensus in adult asthma

314 HCP opinions, 12 recommendations.

A UK consensus on the optimal prescribing of medium strength triple therapy (ICS/LABA/LAMA) in adult asthma patients uncontrolled on an ICS/LABA.

Trimbow^® (beclometasone/formoterol/glycopyrronium) pMDI 87/5/9 is indicated for maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting β₂-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.¹

Please note: the UK Consensus was carried out prior to the BTS/NICE/SIGN joint asthma guidelines publication, and was funded by Chiesi Ltd. The recommendations in the consensus are not based on any specific product.

Are you a healthcare professional?

This promotional website is intended solely for UK healthcare professionals. Please confirm below.

I am a UK healthcare professional Take me to the audience selector

UK-RES-2302115 Oct 2023

PLEASE NOTE

You are now heading to part of ChiesiAir.co.uk which includes promotional content.

Continue Take me back

UK-RES-2200936 July 2022

You are now leaving ChiesiAir.co.uk.

By clicking this link, you will be taken to another Chiesi website.

Confirm Take me back

UK-RES-2102721 Feb 2022

You are now leaving Chiesi’s website

By clicking this link, you will be taken to a website that is not owned or controlled by Chiesi. Chiesi is not responsible for the content provided on that site.